E2 ModerateModerate confidencePEM not requiredMethods-PaperPeer-reviewedMachine draft
Standard · 3 min
The MAPP research network: design, patient characterization and operations.
Landis, J Richard, Williams, David A, Lucia, M Scott et al. · BMC urology · 2014 · DOI
Quick Summary
The MAPP Research Network is a large study designed to understand chronic pelvic pain conditions and related illnesses like fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome. Researchers followed over 1,000 patients at six sites across the United States, collecting detailed information about their symptoms, blood samples, and brain imaging to identify what causes these conditions and how they connect to each other.
Why It Matters
This study is important for ME/CFS patients because it specifically includes Chronic Fatigue Syndrome as a 'positive control' condition, allowing researchers to systematically compare CFS patients with those having other chronic pain conditions. The research reveals how CFS co-occurs with other illnesses and uses advanced phenotyping methods that can help identify shared biological mechanisms across overlapping syndromes, potentially improving diagnosis and treatment strategies.
Observed Findings
Over 1,039 participants were successfully enrolled across six US sites, exceeding original recruitment targets.
Biospecimen collection (blood, cerebrospinal fluid, etc.) was achieved in nearly 100% of baseline participants.
Common neuroimaging was completed in 279 participants using a standardized protocol.
Patients with UCPPS, fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome were characterized alongside healthy age- and sex-matched controls.
An extended follow-up study continues in 161 UCPPS participants to track symptom trajectories over time.
Inferred Conclusions
The high enrollment and biospecimen collection rates demonstrate feasibility of deep phenotyping approaches for complex chronic pain syndromes.
UCPPS, CFS, fibromyalgia, and IBS share enough clinical and biological features to warrant integrated study as non-urologic associated syndromes.
Multi-site, longitudinal characterization combining clinical, molecular, sensory, and neurobiological data is necessary to understand the pathophysiology of these overlapping conditions.
The MAPP network's methodology provides a replicable framework for studying other complex, multi-system disorders.
Remaining Questions
What This Study Does Not Prove
This observational study does not prove causation—it documents associations between UCPPS, CFS, fibromyalgia, and IBS but does not establish that one condition causes another. The study's cross-sectional baseline design cannot definitively determine whether symptom clusters reflect shared underlying biology or separate conditions that coincidentally occur together. Results are specific to the enrolled US population and may not generalize to all patients with these conditions.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
What specific biomarkers or neuroimaging findings distinguish UCPPS from co-occurring CFS, fibromyalgia, or IBS, and do these conditions share common underlying biological pathways?
Do symptom patterns and phenotypic characteristics predict treatment response or long-term prognosis in patients with these overlapping syndromes?
How do infectious agents, quantitative sensory abnormalities, and central nervous system dysfunction contribute mechanistically to symptom development and perpetuation?
What role do psychosocial factors play in the genesis and persistence of symptoms compared to peripheral and central biological mechanisms?